Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Severe drug-induced headache with its possible recurrent statuses in a patient with chronic tension headache

https://doi.org/10.14412/2074-2711-2020-4-73-78

Full Text:

Abstract

The paper deals with the actual problem of managing patients with drug-induced headache (DIH) in patients with primary headaches. It describes a clinical case of extremely severe DIH in a patient with chronic tension headache (TH). The paper analyzes the typical and atypical manifestations of DIH and discusses the role of prolonged stress in the development of TH. Special attention is paid to the problems with therapy and compliance during a long-term follow-up of the patient. Based on the clinical features of pain syndrome in the described patient, the authors suggest for the first time that the use of extremely high number of daily doses of combined narcotic analgesics for many years can result in recurrent DIH statuses. The paper discusses whether it is expedient to introduce the concept “DIH severity” and whether an additional clinical parameter “the number of doses of painkillers per month” can be of informative value, which has not been proposed yet in the literature. All the issues given in the paper are conjectural and are raised by the authors for further investigation of the DIH problem.

About the Authors

V. V. Osipova
Z.P. Solovyev Research and Practical Psychoneurology Center, Moscow Healthcare Department; LTD «University Headache Clinic»
Russian Federation

Vera Valentinovna Osipova

43, Donskaya St., Moscow 115419
2, Molodogvardeiskaya St., Build. 1, Moscow 121467 



K. V. Skorobogatykh
LTD «University Headache Clinic»
Russian Federation
2, Molodogvardeiskaya St., Build. 1, Moscow 121467


A. R. Artemenko
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991


A. V. Sergeev
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia; Center of Neurology, Chaika Clinic
Russian Federation
8, Trubetskaya St., Build. 2, Moscow 119991
9, Lesnaya St., Moscow 125047


References

1. Bigal ME, Lipton RB. Overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep. 2009;13:301-7. doi: 10.1007/s11916-009-0048-3

2. Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine progression: A systematic review. Headache. 2019 Mar;59(3):306-38. doi: 10.1111/head.13459

3. Xu J, Kong F, Buse DC. Predictors of episodic migraine transformation to chronic migraine: A systematic review and meta-analysis of observational cohort studies. Cephalalgia. 2020;40(5):503-16. doi: 10.1177/0333102419883355

4. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol. 1982;33:335-41.

5. Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol. 2007;20(3):326-30. doi: 10.1097/wco.0b013e328136c21c

6. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008;48:1157-68. doi: 10.1111/j.15264610.2008.01217.x

7. Artemenko AR, Kurenkov AL. Khronicheskaya migren' [Chronic migraine]. Moscow: ID «ABVpress»; 2012. 488 p. (In Russ.).

8. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise denovo in association with regular use of analgesics? Headache. 2003;43:179. doi: 10.1046/j.15264610.2003.03041.x

9. Colas R, Munoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004;62(8):1338-42. doi: 10.1212/01.WNL.0000120545.45443.93

10. Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010;11(4):289-99. doi: 10.1007/s10194-010-0217-0

11. Kristoffersen ES, Lundqvist C. Medicationoveruse headache: a review. J Pain Res. 2014;7:367-78. doi: 10.2147/JPR.S46071

12. Kristoffersen ES, Lundqvist C. Medicationoveruse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf. 2014 Apr;5(2):87-99. doi: 10.1177/2042098614522683

13. Linde M, Gustavsson A. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012;19(5):703-11. doi: 10.1111/j.1468-1331.2011.03612.x

14. Diener HC, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019 Sep;18(9):891-902. doi: 10.1016/S14744422(19)30146-2

15. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2017;390:1211-59. doi: 10.1016/S0140-6736(17)32154-2

16. The International Classification of Headache Disorders, 3rd edition (ICHD-3). Cephalalgia. 2018;38(1):1-211. doi: 10.1177/0333102417738202

17. Sergeev AV, Meshcherina MI, Tabeeva GR. Headache associated with excessive usage of analgesics: clinical-psychological and neurophysiological analysis, and specifics of the period of the period of drug withdrawal. Epilepsiya i paroksizmal'nye sostoyaniya. 2011;3(3):21-8 (In Russ.).

18. Latysheva N, Filatova E, Osipova D, Danilov AB. Cognitive impairment in chronic migraine: a cross-sectional study in a clinicbased sample. Arq Neuropsiquiatr. 2020 Mar 30. pii: S0004-282X2020005007201. doi: 10.1590/0004-282X20190159

19. Lai TH, Wang SJ. Neuroimaging findings in patients with medication overuse headache. Curr Pain Headache Rep. 2018;22:1. doi: 10.1007/s11916-018-0661-0


For citation:


Osipova V.V., Skorobogatykh K.V., Artemenko A.R., Sergeev A.V. Severe drug-induced headache with its possible recurrent statuses in a patient with chronic tension headache. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):73-78. (In Russ.) https://doi.org/10.14412/2074-2711-2020-4-73-78

Views: 52


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)